Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Takeda Aims at Top Share for DPP-4 Inhibitors with Nesina
June 7, 2010
- Asahi Kasei Pharma: Sales Down 8.2% to ¥56.0 Bil.
June 7, 2010
- Revlimid, Torisel Recommended for Approval
June 7, 2010
- Mark Smith Appointed President of Merck Serono in Japan
June 7, 2010
- Mr Shoda Elected President of Industry's FTC
May 31, 2010
- Pletaal No. 1 on HP Market, Ecard on GP Market
May 31, 2010
- Sales of Top-8 Domestic Companies Up 2.7%
May 31, 2010
- Shionogi Returns Moxifloxacin to Bayer Yakuhin
May 31, 2010
- Taisho: Sales of Ethical Drugs Up 4.8% to ¥99,590 Mil.
May 31, 2010
- Bufexamac to Be Withdrawn From EU Market
May 31, 2010
- Ono: Sales Down 0.4% Due to Competition with Generics
May 31, 2010
- Nippon Universal Renamed Zydus Pharma
May 31, 2010
- Santen: Sales Up 8.8% Driven by Tapros, Hyalein
May 31, 2010
- Sawai: Sales Exceed ¥50.0 Bil. Benchmark
May 31, 2010
- Kyorin: Mainstay Products Drive Sales Up 9.8% to ¥99.8 Bil.
May 31, 2010
- Towa: Strong Growth in Sales to Pharmacies Drive Business
May 31, 2010
- Kaken: Sales Up 2.5% to ¥85 Bil. Driven by Artz
May 31, 2010
- Nippon Chemiphar: Sales, Profits Up Driven by Generics
May 31, 2010
- Mochida: Sales Up 4.5% to ¥78.5 Bil. Driven by Epadel
May 31, 2010
- Rufinamide to Enter PIII in Japan: Eisai
May 31, 2010
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…